Compare Canopy Growth Corp (CGC) vs Mongodb Inc (MDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Mongodb Inc — how do they compare? Canopy Growth Corp trades at $1.04 (market cap $421.10M), while Mongodb Inc trades at $439.22 (market cap $35.32B). The key difference: Mongodb Inc is far larger — about 83.9× Canopy Growth Corp's market cap, and Mongodb Inc is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | MDB | |
|---|---|---|
Market Cap | $421.10M | $35.32B |
Sector | Health | Technology |
52-Week High | $1.92 | $440.25 |
52-Week Low | $0.86 | $204.37 |
Enterprise Value | $378.55M | $32.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
MongoDB (MDB) trades at $439.54, up 5.49% on the day. The stock exhibits a bullish technical trend, with moving averages and overall signals supporting a buy stance, though oscillators show mixed signals. Fundamentally, revenue growth is strong, reaching $2.01B in 2025, but the company remains unprofitable with a net income margin of -1.12%. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive with 81.81% buy ratings.
The outlook for MDB is optimistic due to robust revenue growth and AI-driven demand, but risks include persistent losses and high valuation multiples. The consensus price target of $404.30 suggests potential downside from current levels, indicating caution despite bullish sentiment. Investors should weigh growth prospects against profitability challenges and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
